ea0063p932 | Diabetes, Obesity and Metabolism 3 | ECE2019
Kuzior Agnieszka
, Fernandez-Trujillo-Comenge Paula Maria
, Nivelo-Rivadeneira Manuel Esteban
, Santana-Suarez Ana Delia
, Acosta-Calero Carmen
, Pedrianes-Matin Pablo Benito
, Zajac Marta Agata
, Martinez-Martin Francisco Javier
Introduction/Aim: Diabetic ketoacidosis is a rare complication in type 2 diabetic patients treated with SGLT2 inhibitors; usually there is a triggering factor (major trauma or surgery, sepsis) or misdiagnosis (type 1 diabetes or LADA). Nivolumab is an anti-CD279 monoclonal antibody used as a second-line immunotherapy in non-small cell lung carcinoma; its use has been associated with fulminant type 1 diabetes and other autoimmune endocrine diseases. We hereby present a case of ...